AzTrials
AzTrials

Oxidative StressNCT03621995

Oxidative Stress in Testicular Tissue Before and After Cryopreservation

An observational study of Oxidative Stress, run by Assiut University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The absence of sperms in ejaculated semen, is the most severe form of male-factor infertility and is present in approximately 5 % of all investigated infertile couples. Read more about this study

Who is it for?
Ages 14 to 80 years, men only
Conditions the study is for
Oxidative Stress
What is being tested?
Malondialdehyde and Catalase level measurement
How many people
58 participants
Where
1 siteEgypt
Study dates
10 Sep 2018to 30 Nov 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 80 years
  • Men only
  • Child, Adult, Older adult

Study population: 45 patients complaining of azoospermia who attended to the Andrology Outpatient Clinic, Dermatology ,Venerology and Andrology department, Assuit University Hospital, Assuit ,Egypt .Patients were divided into 3 groups: * Group A : 15 patients with obustructive azoospermia and positive testicular samples for sperms . * Group B : 15 patients with non obustructive azoospermia and positive testicular samples for sperms. * Group C : 15 patients with azoospermia and negative testicular samples for spems.

Who may be able to join

  • Men with azoospermia at reproductive age .

Who cannot join

  • Pyospermia.
  • Previous trial of cryopreservation.
  • Systemic diseases.
  • Cryptorchidism history.
  • Smoking

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Assuit University Hospital

    Asyut, 71511

Other trials in Egypt

About this study

The absence of sperms in ejaculated semen, is the most severe form of male-factor infertility and is present in approximately 5 % of all investigated infertile couples.

Read the detailed description

Obstructive azoospermia is defined as the absence of spermatozoa in the ejaculate despite normal spermatogenesis.Infection, Iatrogenic injury, Vasectomy and congenital atresia are the possible causes of it. Non obstructive or functional azoospermia results from testicular failure, which is the absence or inadequate production of fully developed spermatozoa within the testes.

Etiologies for testicular failure include genetic disorders such as sexual chromosomal abnormalities ; translocations and microdeletions of the Y chromosome; cryptorchidism; testicular torsion; radiation and toxins.

The advent of intra-cytoplasmic sperm injection has transformed the treatment of this type of severe male-factor infertility.

Surgical techniques for sperm retrieval:Testicular sperm aspiration: In men with obstructive azoospermia ,testicular sperm aspiration invariably generates enough sperm for intra-cytoplasmic sperm injection.

Testicular sperm extraction:This conventional method of surgical sperm extraction generally offers the best chance of retrieving spermatozoa, especially in functional cases and when guided by surgical microscope. However, it can be done by simple open conventional biopsy and closed surgical extraction resembling Trucut biopsy using a special cannula.

Cryopreservation Cryopreservation of human testicular tissue obtained by biopsy can be used as a potential future source of sperms. For adult cancer survivors, cryopreservation of testis biopsies may be the only option remaining if they prefer to father their own biological progeny.

There are 4 types of cryopreservation :

Slow freezing: involves step-wise programmed decrease in temperature. Rapid freezing: was first proposed by . Ultra-rapid freezing :can be considered midway technique between slow freezing and vitrification.

Vitrification: solidifies the sample into a glass-like state. During the freezing process,increasing in susceptibility of spermatozoa to lipid peroxidation,as affected by cold shock, plays an important role in ageing of spermatozoa ,shortening their lifespan and affecting the preservation of semen.The major susceptibility is related in, part to the content of polyunsaturated fatty acids.

Oxidative stress and antioxidants: Oxygen is required to support life, but its metabolites, such as reactive oxygen species, can modify cell functions and endanger cell survival. For this reason,reactive oxygen species is inactivated continuously to maintain only the small amount necessary to maintain normal cell function. There is a balance between the different antioxidants and oxidants at normal status. Oxidative stress is a cellular condition associated with an imbalance between the production of free radicals, mainly reactive oxygen species, and the scavenging capacity of antioxidants.

Superoxide dismutase and catalase are endogenous antioxidants, which protect cells from oxidative stress. Scavengers of reactive oxygen species and antioxidants are important in treating and preventing the damage caused by such stress.

Catalase has been reported from testis, seminal plasma, and spermatozoa Tissue level of malondialdehyde is proven indicator of oxidative stress resulting from lipid peroxidation .

The process of cryopreservation is known to cause more production and/or accumulation of reactive oxygen species, as antioxidant defenses are reduced in the process.

Being tested
Malondialdehyde and Catalase level measurement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Malondialdehyde and Catalase level measurementOther

    Malondialdehyde and Catalase level measurement by colorimetric method

Study groups in NCT03621995
Study groupRoleWhat they receive
Obstructive azoospermiaMalondialdehyde and Catalase level measurement before and after cryopreservation
Receives: Other: Malondialdehyde and Catalase level measurement
Non obstructive azoospermiaMalondialdehyde and Catalase level measurement before and after cryopreservation
Receives: Other: Malondialdehyde and Catalase level measurement
Negative groupMalondialdehyde and Catalase level measurement without cryopreservation
Receives: Other: Malondialdehyde and Catalase level measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of the level of oxidative stress that is caused by cryopreservation of testicular tissue.

    Evaluation of oxidative stress caused by cryopreservation of testicular tissue by measurement of :

    1. Catalase activity as one indicator of antioxidants by colorimetric method.
    2. Malondialdehyde level as one indicator of lipid peroxidation by colorimetric method.

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2018
  2. Study start10 Sep 2018
  3. Primary completion10 Oct 2018
  4. Study completion30 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03621995
Sponsor's protocol ID
OSITTBAAC
Status last verified
Jul 2019
First submitted
20 Jul 2018
Last updated
16 Jul 2019
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Oxidative Stress, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of the level of oxidative stress that is caused by cryopreservation of testicular tissue. (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in